5-hydroxymethylcytosine has been researched along with Stomach Neoplasms in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, EG; Chang, MY; Cheng, Y; Jin, MH; Jin, P; Liu, H; Shu, Q; Wang, X; Xu, T | 1 |
| Akazawa, Y; Hayashi, T; Murakami, T; Nagahara, A; Saito, T; Tsuyama, S; Ueyama, H; Watanabe, S; Yanai, Y; Yao, T; Yatagai, N | 1 |
| He, N; Hou, P; Ji, M; Jin, W; Shi, B; Wu, K; Yang, Q | 1 |
| Cui, DX; Fu, HL; Hou, P; Jin, WL; Li, BJ; Lu, LG; Ma, Y | 1 |
| Du, C; Goto, M; Kahyo, T; Konno, H; Kurabe, N; Matsushima, Y; Ohnishi, I; Shinmura, K; Sugimura, H; Suzuki, M; Tajima, S; Tanioka, F; Tao, H; Yamada, H | 1 |
| Choi, BY; Kang, GH; Kim, HJ; Kim, M; Kim, SY; Kim, YS; Kwon, OH; Lim, B; Park, JL; Seo, EH; Song, KS | 1 |
| Gu, QL; Li, JF; Liu, BY; Pei, YF; Su, LP; Tao, R; Wu, XY; Yan, M; Yu, BQ; Zhu, ZG | 1 |
| Chang, PM; Chou, NH; Kang, CH; Lam, HC; Li, GC; Liu, SI; Tsai, CY; Tsai, KW; Tu, YT; Wang, KC | 1 |
| Aburatani, H; Asaoka, Y; Ijichi, H; Koike, K; Kudo, Y; Nagae, G; Tateishi, K; Yamamoto, K; Yamamoto, S; Yoshida, H | 1 |
9 other study(ies) available for 5-hydroxymethylcytosine and Stomach Neoplasms
| Article | Year |
|---|---|
Altered 5-Hydroxymethylcytosine Landscape in Primary Gastric Adenocarcinoma.
Topics: 5-Methylcytosine; Adenocarcinoma; Case-Control Studies; DNA Methylation; Epigenesis, Genetic; Genome, Human; Humans; Stomach Neoplasms | 2019 |
TP53 inactivation and expression of methylation-associated proteins in gastric adenocarcinoma with enteroblastic differentiation.
Topics: 5-Methylcytosine; Adenocarcinoma; Aged; Aged, 80 and over; Ataxia Telangiectasia Mutated Proteins; Biomarkers, Tumor; Cell Differentiation; DNA Methylation; Female; Gene Silencing; Humans; Loss of Heterozygosity; Lymphatic Metastasis; Male; Middle Aged; Mixed Function Oxygenases; Mutation; Neoplasm Staging; Promoter Regions, Genetic; Proto-Oncogene Proteins; Stomach Neoplasms; Treatment Outcome; Tumor Suppressor Protein p53 | 2019 |
Decreased 5-hydroxymethylcytosine (5-hmC) is an independent poor prognostic factor in gastric cancer patients.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; China; Cytosine; Female; Humans; Incidence; Male; Middle Aged; Prognosis; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Stomach Neoplasms; Survival Analysis; Survival Rate | 2013 |
TET1 exerts its tumor suppressor function by interacting with p53-EZH2 pathway in gastric cancer.
Topics: 5-Methylcytosine; Animals; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Cytosine; Dioxygenases; DNA-Activated Protein Kinase; DNA-Binding Proteins; Down-Regulation; Enhancer of Zeste Homolog 2 Protein; Gastric Mucosa; Humans; Ki-67 Antigen; Mice; Mixed Function Oxygenases; Nuclear Proteins; Phosphorylation; Phosphoserine; Polycomb Repressive Complex 2; Protein Binding; Proto-Oncogene Proteins; Signal Transduction; Stomach Neoplasms; Tissue Array Analysis; Tumor Suppressor Protein p53; Up-Regulation | 2014 |
Robust quantitative assessments of cytosine modifications and changes in the expressions of related enzymes in gastric cancer.
Topics: 5-Methylcytosine; Aged; Chromatography, Liquid; Cytosine; Deoxycytidine; Dioxygenases; DNA-Binding Proteins; Enzymes; Female; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Mixed Function Oxygenases; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins; Stomach Neoplasms; Tandem Mass Spectrometry | 2015 |
Decrease of 5hmC in gastric cancers is associated with TET1 silencing due to with DNA methylation and bivalent histone marks at TET1 CpG island 3'-shore.
Topics: 3' Untranslated Regions; 5-Methylcytosine; Chromatin Immunoprecipitation; CpG Islands; Cytosine; DNA Methylation; Female; Gene Silencing; Histone Code; Humans; Immunoenzyme Techniques; Male; Middle Aged; Mixed Function Oxygenases; Proto-Oncogene Proteins; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Stomach Neoplasms; Tumor Cells, Cultured | 2015 |
TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression.
Topics: 5-Methylcytosine; Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; CpG Islands; Demethylation; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mixed Function Oxygenases; Neoplasm Metastasis; Promoter Regions, Genetic; Protein Binding; Proto-Oncogene Proteins; PTEN Phosphohydrolase; RNA Interference; Stomach Neoplasms; Transplantation, Heterologous | 2016 |
Isocitrate Dehydrogenase 2 Dysfunction Contributes to 5-hydroxymethylcytosine Depletion in Gastric Cancer Cells.
Topics: 5-Methylcytosine; Cytosine; DNA Methylation; Female; Humans; Isocitrate Dehydrogenase; Ketoglutaric Acids; Male; Stomach Neoplasms | 2016 |
Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation.
Topics: 5-Methylcytosine; Cell Line, Tumor; Cell Transformation, Neoplastic; Colorectal Neoplasms; Cytosine; DNA Methylation; DNA-Binding Proteins; Gene Knockdown Techniques; Humans; Mixed Function Oxygenases; Mutation; Neoplasms; Proto-Oncogene Proteins; Stomach Neoplasms | 2012 |